Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ritz

Showing results (261-270 of 297) with videos related to

Pageof 30
Sort By:
Transplantation|December 1, 1991
Hepatic dysfunction following T-cell-depleted allogeneic bone marrow transplantationR J Soiffer, K Dear, S N Rabinowe, et al.
Human Molecular Genetics|February 5, 1999
PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignanciesP L Dahia, R C Aguiar, J Alberta, et al.
Blood|February 1, 1987
Hematologic engraftment and immune reconstitution posttransplantation with anti-B1 purged autologous bone marrowK C Anderson, J Ritz, T Takvorian, et al.
Bone Marrow Transplantation|August 1, 1991
Successful treatment of disseminated Fusarium infection after autologous bone marrow transplantation for acute myeloid leukemiaM J Robertson, M A Socinski, R J Soiffer, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 21, 2001
CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemiaX F Yang, C J Wu, S McLaughlin, et al.
Blood|June 1, 1981
Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphomaA Bernard, L Boumsell, E L Reinherz, et al.
Bone Marrow Transplantation|January 16, 2013
KIR ligand incompatibility is not associated with relapse reduction after double umbilical cord blood transplantationA Garfall, H T Kim, L Sun, et al.
Blood|January 1, 1983
Differentiation patterns in the blastic phase of chronic myeloid leukemiaJ D Griffin, R F Todd, J Ritz, et al.
Blood|October 1, 1996
High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remissionA S Freedman, J G Gribben, D Neuberg, et al.
Blood|March 15, 1996
Transcript synthesis and surface expression of the interleukin-2 receptor (alpha-, beta-, and gamma-chain) by normal and malignant myeloid cellsR R Schumann, T Nakarai, H J Gruss, et al.
Pageof 30

Showing results (261-270 of 297) with videos related to

Sort By:
Pageof 30
Transplantation|December 1, 1991
Hepatic dysfunction following T-cell-depleted allogeneic bone marrow transplantationR J Soiffer, K Dear, S N Rabinowe, et al.
Human Molecular Genetics|February 5, 1999
PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignanciesP L Dahia, R C Aguiar, J Alberta, et al.
Blood|February 1, 1987
Hematologic engraftment and immune reconstitution posttransplantation with anti-B1 purged autologous bone marrowK C Anderson, J Ritz, T Takvorian, et al.
Bone Marrow Transplantation|August 1, 1991
Successful treatment of disseminated Fusarium infection after autologous bone marrow transplantation for acute myeloid leukemiaM J Robertson, M A Socinski, R J Soiffer, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 21, 2001
CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemiaX F Yang, C J Wu, S McLaughlin, et al.
Blood|June 1, 1981
Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphomaA Bernard, L Boumsell, E L Reinherz, et al.
Bone Marrow Transplantation|January 16, 2013
KIR ligand incompatibility is not associated with relapse reduction after double umbilical cord blood transplantationA Garfall, H T Kim, L Sun, et al.
Blood|January 1, 1983
Differentiation patterns in the blastic phase of chronic myeloid leukemiaJ D Griffin, R F Todd, J Ritz, et al.
Blood|October 1, 1996
High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remissionA S Freedman, J G Gribben, D Neuberg, et al.
Blood|March 15, 1996
Transcript synthesis and surface expression of the interleukin-2 receptor (alpha-, beta-, and gamma-chain) by normal and malignant myeloid cellsR R Schumann, T Nakarai, H J Gruss, et al.
Pageof 30